APRI Insider Trading Activity and SEC Form 4 Filings
APRI insider trading summary
No open-market insider purchases or sales of Apricus Biosciences, Inc. (APRI) have been reported on SEC Form 4 in the past 12 months.
Latest APRI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 31, 2017 | Sarissa Capital Domestic Fund LP | 10% Owner | Buy | $10K (6,104 @ $1.63) |
| Aug 31, 2017 | Sarissa Capital Management LP | 10% Owner | Buy | $10K (6,104 @ $1.63) |
| Aug 31, 2017 | Alexander J Denner | 10% Owner | Buy | $10K (6,104 @ $1.63) |
| Aug 31, 2017 | Sarissa Capital Offshore Master Fund LP | 10% Owner | Buy | $10K (6,104 @ $1.63) |
| Mar 3, 2016 | Sarissa Capital Offshore Master Fund LP | 10% Owner | Buy | $5.9M (6,647,728 @ $0.88) |
| Mar 3, 2016 | Sarissa Capital Management LP | 10% Owner | Buy | $5.9M (6,647,728 @ $0.88) |
| Mar 3, 2016 | Alexander J Denner | 10% Owner | Buy | $5.9M (6,647,728 @ $0.88) |
| Mar 3, 2016 | Sarissa Capital Domestic Fund LP | 10% Owner | Buy | $5.9M (6,647,728 @ $0.88) |
| Jan 12, 2016 | Alexander J Denner | 10% Owner | Buy | $1.2M (1,306,819 @ $0.88) |
| Jan 12, 2016 | Sarissa Capital Domestic Fund LP | 10% Owner | Buy | $1.2M (1,306,819 @ $0.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.